{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-055950","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2024-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.548212+00:00","generated_at":"2026-06-01T01:20:16.142538+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Oramed authorizes up to $20M stock buyback program over 12 months","bullets":["Board authorized up to $20M in common stock repurchases, expiring in 12 months.","Repurchases may be on open market or private transactions under Rule 10b-18.","Program does not obligate purchase; can be terminated or modified by Board at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-055950","json":"https://secwatch.observer/filing/0001213900-24-055950.json","markdown":"https://secwatch.observer/filing/0001213900-24-055950.md","text":"https://secwatch.observer/filing/0001213900-24-055950.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024055950/0001213900-24-055950-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024055950/ea0208443-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:20:16.142538+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}